Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Caligiuri, Michael A  [Clear All Filters]
Journal Article
Zhang B, Zhao D, Chen F, Frankhouser D, Wang H, Pathak KV, Dong L, Torres A, Garcia-Mansfield K, Zhang Y, et al. Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisis. Nat Commun. 2023;14(1):5325.
Ali S, Mansour AG, Huang W, Queen NJ, Mo X, Anderson JM, Ii QNHassan, Patel RS, Wilkins RK, Caligiuri MA, et al. CSF1R inhibitor PLX5622 and environmental enrichment additively improve metabolic outcomes in middle-aged female mice. Aging (Albany NY). 2020;12.
Bergin SM, Xiao R, Huang W, C Judd RT, Liu X, Mansour AG, Queen N, Widstrom KJ, Caligiuri MA, Cao L. Environmental activation of a hypothalamic BDNF-adipocyte IL-15 axis regulates adipose- natural killer cells. Brain Behav Immun. 2021.
Mundy-Bosse BL, Weigel C, Wu Y-Z, Abdelbaky S, Youssef Y, Casas SBeceiro, Polley N, Ernst G, Young KA, McConnell KK, et al. Identification and Targeting of the Developmental Blockade in Extranodal Natural Killer/T-cell Lymphoma. Blood Cancer Discov. 2022;3(2):154-169.
Mansour AG, Teng K-Y, Li Z, Zhu Z, Chen H, Tian L, Ali A, Zhang J, Lu T, Ma S, et al. Off-the-Shelf CAR-Engineered Natural Killer Cells Targeting FLT3 Enhance Killing of Acute Myeloid Leukemia. Blood Adv. 2023.
Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, et al. PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest. 2013.